Article
Azole‐resistant Candida spp. – emerging pathogens?
2012-04-01
Abstract excerpt
Summary Invasive fungal infections cause significant morbidity and mortality in immunocompromised patients. Azoles, and fluconazole in particular, are very active against Candida albicans, and are used widely because of their good tolerability. However, the increasing use of azole antifungals for the treatment of mucosal and systemic Candida infections has resulted in the selection and/or emergence of resistant Ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f6cd08e-0aa9-50c6-9db6-51adae48358a
- DOI
- 10.1111/j.1439-0507.2011.02146.x
